With the Anglonordic Life Science Conference last week, BioEquity next week, ASGCT Annual meeting and LSX Nordic Congress around the corner, it is a good time to practice your pitching. Funds are open and now is the time to foster those new and old connections. Read on to discover what has happened this week and […]
Biotechs are becoming increasingly cautious about what they publish in scientific journals. The growing worry is that other companies, often based in China, will take the freshly published information and run with it – and go on to develop a target or very early stage drug much faster than the originator. This was a subject raised last week on a panel at the Anglonordic Life Science Conference in London, by Dr Adi Hoess, CEO […]
A profoundly positive response from Anglonordic attendees with hands shaken, conversations started and potential deals in the works. The main takeaway was the benefit of it being a ‘boutique’ event, meaning everyone could make the most of the 1:1 partnering, pitch presentations, and networking breaks. Keep reading to hear more about what’s been happening this […]
I spent 20 years as a print journalist and my first love will always be the written word. But you might have noticed we’ve switched our Hot Topic articles from being a purely written affair, to something that we deliver primarily by video. There’s a very simple reason for this. Video gets more views. Way […]
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease R1 Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on the development of first-in-class therapies for patients with kidney disease, announced its launch with an oversubscribed $77.5 million Series A financing, along with the […]
